Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Methadone price, strengths & recalls

Pharmacies pay $5.45 for 30 tablets of Methadone 10 mg tablet this week, and from $4.95 to $528.32 across its 3 priced strengths and forms. 16 manufacturers make it. 1 recall is ongoing. Its official label last changed on August 11, 2026.

1 open recallGeneric
Pharmacies pay$5.45for 30 tablets of 10 mg tablet+2.7% in 4 weeks
Fair cash price
$16.77
Strengths
3
Makers
16
Updated
Nov 11

Methadone price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
10 mg/mL injectionNot priced this week
1 mg/mL oral solutionNot priced this week
2 mg/mL oral solutionNot priced this week
10 mg/mL oral solution$0.5283$528.32 / 1000 mL-2.6%-2.4%
5 mg tablet$0.1649$4.95 / 30 tablets+2.1%-12.1%
10 mg tablet$0.1817$5.45 / 30 tablets+2.7%-5.2%
40 mg tablet for oral suspensionNot priced this week

The lowest cost per tablet is 5 mg tablet at $0.1649. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
1 ongoing recall11 recalls on record, latest Jan 15, 2025

Recalls

Showing the 6 most relevant of 11 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for methadone? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedAugust 11, 2026
Version18 of 16
EffectiveDec 31, 2025
Read the label

This drug has a boxed warning

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF METHADONE HYDROCHLORIDE INJECTION

Addiction, Abuse, and Misuse

Because the use of Methadone Hydrochloride Injection exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions (see WARNINGS).

Life-Threatening Respiratory Depression

Serious, life-threatening, or fatal respiratory depression may occur with use of Methadone Hydrochloride Injection, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of Methadone Hydrochloride Injection are essential (see WARNINGS).

Neonatal Opioid Withdrawal Syndrome (NOWS)

Neonatal opioid withdrawal syndrome (NOWS) is an expected and treatable outcome of use of Methadone Hydrochloride Injection during pregnancy. NOWS may be life-threatening if not recognized and treated in the neonate. The balance between the risks of NOWS and the benefits of maternal Methadone Hydrochloride Injection use may differ based on the risks associated with the mother's underlying condition, pain, or addiction. Advise the patient of the risk of NOWS so that appropriate planning for management of the neonate can occur (see WARNINGS).

Managing Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants

Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of Methadone Hydrochloride Injection and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate (see WARNINGS, PRECAUTIONS).

Life-Threatening QT Prolongation

QT interval prolongation and serious arrhythmia (torsades de pointes) have occurred during treatment with methadone. Most cases involve patients being treated for pain with large, multiple daily doses of methadone, although cases have been reported in patients receiving doses commonly used for maintenance treatment of opioid addiction. Closely monitor patients with risk factors for development of prolonged QT interval, a history of cardiac conduction abnormalities, and those taking medications affecting cardiac conduction for changes in cardiac rhythm during initiation and titration of Methadone Hydrochloride Injection (see WARNINGS).

Interactions with Drugs Affecting Cytochrome P450 Isoenzymes

The concomitant use of Methadone Hydrochloride Injection with all cytochrome P450 3A4, 2B6, 2C19, 2C9 or 2D6 inhibitors may result in an increase in methadone plasma concentrations, which could cause potentially fatal respiratory depression. In addition, discontinuation of concomitantly used cytochrome P450 3A4 2B6, 2C19, or 2C9 inducers may also result in an increase in methadone plasma concentration. Follow patients closely for respiratory depression and sedation and consider dosage reduction with any changes of concomitant medications that result in an increase in methadone levels (see WARNINGS, PRECAUTIONS: Drug Interactions).

Conditions for Distribution and Use of Methadone Products for the Treatment of Opioid Addiction

For detoxification and maintenance of opioid dependence, methadone should be administered in accordance with the treatment standards cited in 42 CFR Section 8, including limitations on unsupervised administration (see INDICATIONS AND USAGE).

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA021624 · Mylan Institutional
First approved
August 13, 1947 (79 years ago)
Latest approved change
December 22, 2025
Approved label
PDF, Jan 6, 2026
Generic makers
20 approved generic applications on the market

Methadone questions

How much does methadone cost without insurance?

Pharmacies pay about $5.45 for 30 tablets of methadone 10 mg tablet ($0.1817 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $16.77. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is methadone in shortage?

No shortage is reported for methadone right now. We check the national shortage list every day.

Has methadone been recalled?

11 recalls on record, 1 ongoing. Recalls name specific lots - check yours.

When did the methadone label last change?

The official label was last updated on August 11, 2026 (version 18). See what changed.

Talk about methadone

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.